FindTrial
Sign In

A series of studies on central venous oxygen saturation as blood transfusion threshold in liver transplantation

A series of studies on central venous oxygen saturation as blood transfusion threshold in liver transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057740
Enrollment
Unknown
Registered
2022-03-16
Start date
2023-07-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental group:Central venous oxygen saturation as blood transfusion threshold
Control group:Hemoglobin concentration as transfusion threshold

Sponsors

Department of Anesthesiology, the Third Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. End-stage liver disease due to various causes; 2. Primary liver cancer (HCC) without distant metastasis or invasion of large vessels; 3. Cardiopulmonary function can tolerate liver transplantation.

Exclusion criteria

Exclusion criteria: 1. Hypermagnesia before surgery; 2. Hypothyroidism; 3. Combined with other organ transplant patients; 4. Patients refuse to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
Intraoperative blood transfusion rate;Type of intraoperative blood transfusion ;—

Secondary

MeasureTime frame
Basic vital indicators;The concentrations of sodium, potassium and calcium in the anastomotic effluents were measured;Use of various rescue drugs during operation;Condition of recovery;—

Countries

China

Contacts

Public ContactQie Xiaojuan

Third Hospital of Hebei Medical University

qiexiaojuan@163.com+86 131 0301 9189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026